Lansoprazol Sandoz (Lansoprazole)

Lansoprazol Sandoz is a proton pump inhibitor that lowers gastric acidity, providing therapeutic benefit across several acid‑related gastrointestinal disorders.

• Gastro‑esophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing stomach acid.
• Peptic ulcer disease: promotes ulcer healing and prevents recurrence through acid suppression.
• Helicobacter pylori eradication: used as part of combination therapy to eradicate H. pylori infection.
• Erosive esophagitis: heals inflamed esophageal tissue by maintaining a higher gastric pH.

• Lansoprazole selectively and irreversibly inhibits the H+/K+ ATPase (proton pump) located on the secretory surface of gastric parietal cells. By blocking this final step of acid production, it markedly reduces both basal and stimulated gastric acid secretion, leading to an increased gastric pH and facilitating mucosal healing in acid‑related disorders.

Lansoprazol Sandoz may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: watery stools, usually self‑limiting.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Clostridioides difficile infection: persistent diarrhea with possible fever.
• Low magnesium levels: muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.

Before initiating therapy with Lansoprazol Sandoz, consider the following safety measures.

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review concomitant medications: avoid drugs that require acidic environment for absorption.
• Monitor for infection: prolonged acid suppression can increase risk of gastrointestinal infections.
• Use with caution in elderly patients: higher incidence of bone fractures.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazol Sandoz can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Antifungal agents such as ketoconazole: reduced absorption leading to therapeutic failure.
• HIV protease inhibitors (e.g., atazanavir): markedly decreased plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in anticoagulant effect, monitor INR.
• Digoxin: may increase serum levels, observe for toxicity.
• Methotrexate (high dose): reduced clearance, monitor renal function and drug levels.